A randomized, double-blind, 6-week prospective pilot study on the efficacy and safety of dose escalation in non-remitters in comparison to those of the standard dose of escitalopram for major depressive disorder
Kim, Kim, Lee, Lee, Kim, Park, Ahn (2019) A randomized, double-blind, 6-week prospective pilot study on the efficacy and safety of dose escalation in non-remitters in comparison to those of the standard dose of escitalopram for major depressive disorder J Affect Disord (IF: 6.6) 259 91-97Links
http://www.ncbi.nlm.nih.gov/pubmed/31445345http://dx.doi.org/10.1016/j.jad.2019.08.057
